spacer
home > pmps > winter 2017 > thinking human
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Thinking Human

Two main challenges with human factors (HF) stand out at the moment: one is that it has become a ‘hot topic’ that people do not want to hear about anymore; the other is that it is perhaps not clear what the lasting and valuable contribution of it will be. However, it can have real benefits in the development of inhalers. It is important to look at the HF perspective and how it might contribute to future advancements in both medical devices and technology.

Innovative Inhalers


It is not helpful for HF to be possessive, or seek to claim ownership of any particular aspect of the development of inhalers or their life in the world. This perspective is just one voice among many, and countless progressions in inhalers occurred before HF were identified as an integral part of the design process. There are three aspects of the inhaler-user relationship where the industry looks to improve.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Julian Dixon is Director of HF at Team Consulting, the leading medical device development consultancy based in Cambridge, UK. He takes an active role in understanding emerging FDA expectations and practices with regard to HF, particularly as they apply to combination products. Predominantly in the respiratory and parenteral sectors, Julian has worked on a large number of drug delivery device development projects and has fulfilled a range of consultancy roles for clients including HF, facilitation, decision support and technical problem solving.
spacer
Julian Dixon
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Kallik’s Release 6 sets new benchmarks for speed, accuracy and efficiency

Tamworth, UK – 15 June 2019 – Global provider of labelling and artwork management solutions, Kallik, is launching an update to its AMS360 solution – its Release 6, transforming the experience of the business user, whilst defining new benchmarks for speed, accuracy, and efficiency of global labelling and artwork processes.
More info >>

White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement